Asperlicin
Asperlicin is a cholecystokinin antagonist that was first isolated from the fungus Aspergillus alliaceus. It is a non-peptide molecule that has been found to have significant effects on the gastrointestinal system and the central nervous system.
History[edit | edit source]
Asperlicin was first isolated in 1986 from the fungus Aspergillus alliaceus. The discovery of this compound marked a significant advancement in the field of pharmacology, as it was the first non-peptide antagonist of cholecystokinin to be discovered.
Structure and Properties[edit | edit source]
Asperlicin is a complex molecule with a unique structure. It is a tetramic acid derivative, and its structure includes a pyrrolidine ring and a quinazolinone moiety. This complex structure is believed to be responsible for its unique pharmacological properties.
Pharmacology[edit | edit source]
Asperlicin acts as an antagonist of the cholecystokinin receptor, specifically the CCK-A subtype. Cholecystokinin is a hormone that plays a crucial role in the regulation of the gastrointestinal system and the central nervous system. By blocking the action of cholecystokinin, asperlicin can affect a variety of physiological processes, including gastric acid secretion, gallbladder contraction, and pancreatic enzyme secretion.
Clinical Significance[edit | edit source]
Due to its unique pharmacological properties, asperlicin has been the subject of numerous studies in the field of medicine. It has been found to have potential therapeutic applications in the treatment of various conditions, including pancreatitis, gastroesophageal reflux disease, and certain types of cancer. However, further research is needed to fully understand the potential benefits and risks of this compound.
See Also[edit | edit source]
Resources[edit source]
Latest articles - Asperlicin
AI tools[edit source]
Generative AI tools and links to learn more on Asperlicin: ChatGPT - Bing Chat - Google Gemini. (caution advised).
Translate: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD